Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP958826.RA6-SMX58atOIfk55EmbNLt2tj-iAzyVz11ZFv5zKP9Yk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP958826.RA6-SMX58atOIfk55EmbNLt2tj-iAzyVz11ZFv5zKP9Yk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP958826.RA6-SMX58atOIfk55EmbNLt2tj-iAzyVz11ZFv5zKP9Yk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP958826.RA6-SMX58atOIfk55EmbNLt2tj-iAzyVz11ZFv5zKP9Yk130_provenance.
- NP958826.RA6-SMX58atOIfk55EmbNLt2tj-iAzyVz11ZFv5zKP9Yk130_assertion description "[Because RALBP1 transports anthracycline and Vinca alkaloid drugs, as well as GS-E, and because it confers resistance to these drugs, we proposed that depletion or inhibition of RALBP1 should cause regression of human solid tumors that overexpress RALBP1 and augment chemotherapy efficacy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP958826.RA6-SMX58atOIfk55EmbNLt2tj-iAzyVz11ZFv5zKP9Yk130_provenance.
- NP958826.RA6-SMX58atOIfk55EmbNLt2tj-iAzyVz11ZFv5zKP9Yk130_assertion evidence source_evidence_literature NP958826.RA6-SMX58atOIfk55EmbNLt2tj-iAzyVz11ZFv5zKP9Yk130_provenance.
- NP958826.RA6-SMX58atOIfk55EmbNLt2tj-iAzyVz11ZFv5zKP9Yk130_assertion SIO_000772 17483352 NP958826.RA6-SMX58atOIfk55EmbNLt2tj-iAzyVz11ZFv5zKP9Yk130_provenance.
- NP958826.RA6-SMX58atOIfk55EmbNLt2tj-iAzyVz11ZFv5zKP9Yk130_assertion wasDerivedFrom befree-20150227 NP958826.RA6-SMX58atOIfk55EmbNLt2tj-iAzyVz11ZFv5zKP9Yk130_provenance.
- NP958826.RA6-SMX58atOIfk55EmbNLt2tj-iAzyVz11ZFv5zKP9Yk130_assertion wasGeneratedBy ECO_0000203 NP958826.RA6-SMX58atOIfk55EmbNLt2tj-iAzyVz11ZFv5zKP9Yk130_provenance.
- befree-20150227 importedOn "2015-02-27" NP958826.RA6-SMX58atOIfk55EmbNLt2tj-iAzyVz11ZFv5zKP9Yk130_provenance.